Cantitate/Preț
Produs

Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques

Editat de Joseph D. Feuerstein, Adam S. Cheifetz
en Limba Engleză Hardback – 6 iul 2019
This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. 

Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.
Citește tot Restrânge

Preț: 34924 lei

Preț vechi: 36763 lei
-5% Nou

Puncte Express: 524

Preț estimativ în valută:
6689 7252$ 5561£

Carte disponibilă

Livrare economică 11-25 noiembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030153007
ISBN-10: 3030153002
Pagini: 184
Ilustrații: XI, 174 p. 14 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.41 kg
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases.- Screening for Colon Cancer in Inflammatory Bowel Disease.- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease.- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease.- Lymphoma Risk and Screening in Inflammatory Bowel Disease.- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases.- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease.- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases.- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches.- Cancer Risk and Screening in Pediatric Patients.- Colorectal Cancer Risk and Screening in Geriatric Patients.- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.

Notă biografică

Joseph D. Feuerstein, MD
Beth Israel Deaconess Medical Center
Center for Inflammatory Bowel Disease
Harvard Medical School
Boston, MA
USA

Adam S. Cheifetz, MD
Beth Israel Deaconess Medical Center
Center for Inflammatory Bowel Disease
Harvard Medical School
Boston, MA
USA

Textul de pe ultima copertă

This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. 

Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.

Caracteristici

Thoroughly profiles most malignancies associated with IBD Reviews best methods to effectively reduce cancer risks in patients with IBD Written by experts in the field